Kymera Therapeutics, Inc. announced the appointment of Leigh Morgan to its Board of Directors. Ms. Morgan joins Kymera's Board as a senior executive accomplished in scaling global, profitable, high-performing organizations. Ms. Morgan brings deep human resource, operations, strategy, businesses and people integration, and public-private partnership competencies to Kymera's board.

In her current role as Chief Strategy and Operating Officer for Nia Tero, she is a key architect of the firm's growth, inclusive of strategy, finance, innovation, communications, operations, impact investments and governance. Ms. Morgan previously served as Chief Operating Officer of the Bill & Melinda Gates Foundation where she oversaw a broad portfolio, including human resources, information technology and security, facilities and the foundation's culture transformation efforts. Her health and biotechnology leadership roles include serving as Associate Chancellor at the University of California, San Francisco, Vice President and Global Head of Human Resources for Product Development at Genentech, and HR leadership roles at GSK.

She serves as Vice-Chair/Chair-elect of the Board at the Fred Hutch Cancer Center, is on the University of Washington Medical Center Advisory Board, and is an independent director at Curemark, a clinical-stage biotechnology company. She holds a master's degree in organization development from the American University and a bachelor's degree from Duke University. She was awarded an honorary doctorate from the Asian University for Women in Bangladesh and is a member of the Council on Foreign Relations.